Microbot Medical (MBOT) Operating Income (2010 - 2026)

Microbot Medical has reported Operating Income for 17 years, with the latest figure at -$4.3 million in Q1 2026.

• For the quarter ending Q1 2026, Operating Income fell 43.0% year-over-year to -$4.3 million; the trailing twelve-month figure through Mar 2026 stood at -$16.0 million (down 30.83% YoY), and the FY2025 full-year result was -$14.7 million, down 26.82% from the prior year.
• Operating Income for Q1 2026 stood at -$4.3 million, down from -$4.1 million in the prior quarter.
• The five-year high for Operating Income was -$2.1 million in Q4 2023, with the low at -$4.3 million in Q1 2026.
• Historically, Operating Income has averaged -$3.2 million across 5 years, with a median of -$3.2 million in 2022.
• Annual changes were most pronounced in 2023 — Operating Income surged 34.77% — and 2024, when it tumbled 65.86%.
• Microbot Medical's Operating Income stood at -$3.1 million in 2022, then surged by 32.59% to -$2.1 million in 2023, then plunged by 65.86% to -$3.4 million in 2024, then dropped by 20.64% to -$4.1 million in 2025, then retreated by 4.4% to -$4.3 million in 2026.
• The last three Operating Income figures came in at -$4.3 million (Q1 2026), -$4.1 million (Q4 2025), and -$3.9 million (Q3 2025), per Business Quant data.